Story of Chugai
Stories
A Story of Paving the Way to the Future,
Thinking
of Patients' Happiness
So many people around the world still suffer from diseases that have no cure.
Chugai aims to deliver effective treatments and services through the power of innovation, with the goal of bringing happiness to patients.
To achieve this, each employee pursues the creation of continuous innovation with fresh ideas that are not bound by conventional wisdom.
Realizing advanced and sustainable patient-centric healthcare.
We present to you the story of our employees' challenges as they forge ahead on uncharted paths, always keeping in mind the happiness of patients that lies beyond.
PICK UP
Mar 06, 2025
The Bio Lab’s Development of the Next Generation of Scientists
One of Chugai Pharmaceutical’s research centers is the Chugai Life Science Park Yokohama in Totsuka-ku, Yokohama City. Within this center is the BIO LAB,
- Sustainability
- Social Contribution
- Bio Lab
Mar 06, 2025
The Chugai Pharmaceutical Group considers global environmental protection to be an important foundation for all its business activities, and has set three
- Global Environment
- Supply Chain Management
Display Conditions
-
CHUGAI INNOVATION DAY 2024 Report—More Than 3,000 in Attendance
Chugai Pharmaceutical’s CHUGAI INNOVATION DAY 2024 was hosted on November 25 (Mon) and 26 (Tue), 2024. This was the fifth hosting of the CHUGAI INNOVATION
- Innovation
- R&D
- DX
- Event
-
Takao Suzuki was previously an employee at Microsoft where he supported numerous companies as director of the DX strategy advisory department. He now works as Head of the DX Unit at Chugai Pharmaceutical. According to Suzuki, what are the key factors to ensuring the successful implementation of DX?
Aiming to become the top innovator in the healthcare industry, Chugai Pharmaceutical has positioned DX as a fundamental element of its growth strategy. Phase 1
- Innovation
- DX
- CHUGAI DIGITAL VISION 2030
- Top Interview
-
Greater Efficiency in Bioprocess Development. Digital Transformations in Pharmaceuticals
Chugai Pharmaceutical is currently promoting companywide DX to achieve the targets of its new growth strategy Top I 2030. The company is focusing on innovative
- Innovation
- R&D
- DX
- Sustainability
- CHUGAI DIGITAL VISION 2030
- Production Technology
-
Working Toward Greater Efficiency in the Drug Discovery Process for Mid-size Molecules. Development of a Crystallization Confirmation App Using Agile Development Methods
Agile development has recently been garnering attention as a method that involves quickly ascertaining needs and progressing with a project in an agile and
- Innovation
- R&D
- DX
- Mid-Molecule Pharmaceuticals
-
Supporting the transformation of business with global-standard systems infrastructure. Stories from behind the scenes of the ERP system renewal project and the sense of reward that it gives, as discussed by staff working on the next-generation core business (ERP) system
With the promotion of DX, expectations are growing for the appropriate use of information about companies’ management resources. At Chugai Pharmaceutical
- R&D
- DX
- Recruitment
- IT Infrastructure
-
Leading the optimization of ICT infrastructure. Making advanced solutions a strength in Chugai Pharmaceutical’s business transformation
Sasaki is a member of the IT Solution Department. As Group Manager of a group that is responsible for applications used in the R&D field, from introduction
- DX
- Recruitment
- IT Infrastructure
-
Next-generation pharmaceutical lead by digital technology Taking on innovative drug development with a data-driven approach
The Pharmaceutical Technology Division is in charge of the development process leading to the commercialization of candidate molecules. Within that division,
- R&D
- DX
- Recruitment
- Drug Discovery Modalities
- Production Technology
-
Supporting DX with substantive risk management. To take the lead in cybersecurity to realize word-class drug discovery
Concurrently with its promotion of digital transformation (DX), Chugai Pharmaceutical is strengthening cybersecurity measures for the entire Group, including
- DX
- Recruitment
- Supply Chain Management
- Cybersecurity
-
Maximizing Drug Discovery Through Team Capabilities. Delivering Innovative Drugs to Patients with Process and Technological Development
Kondo is an employee at the pharmaceutical research department. Within his group, in addition to overseeing process development and manufacturing technology
- Innovation
- R&D
- DX
- Recruitment
- Mid-Molecule Pharmaceuticals
- Production Technology
-
Realizing patient-centric clinical trials with DX. Decentralized clinical trials (DCT) initiative to achieve patient-centricity and more efficient clinical studies simultaneously
“We want to create a society that enables the choice of clinical trial methods that are closer to patients. The realization of DCT is expected to
- R&D
- DX
- Clinical Trials
-
Accelerating DX with open innovation. The future of healthcare aimed for through company-wide awareness reform
Yanaizu belongs to the Digital Strategy Department which leads Chugai Pharmaceutical’s digital transformation (DX). Since joining the company in 2023, she
- R&D
- DX
- Partnering
- CHUGAI DIGITAL VISION 2030